Meet Our Team - Tarun Bhagnani, Associate Director, Market Access

September 8, 2022

Meet our Associate Director of Market Access, Tarun Bhagnani.

Tarun Bhagnani

Servier’s “Meet Our Team” series introduces our talented and diverse team that works tirelessly to bring the promise of tomorrow to our patients!

Tarun leads real-world evidence generation and payer marketing initiatives to demonstrate the value of Servier’s products. This includes developing strategies and implementing tactics to help ensure our company’s growth and success in delivering value to patients. 

What is your favorite part about working at Servier Pharmaceuticals? 

My favorite part about working at Servier is the having numerous opportunities to collaborate with talented individuals each day as we come together to bring life-saving medicines to patients.  

I enjoy working in an environment that is built upon core values, such as care, dare to innovate, commit to succeed and grow by sharing. 

What do you love most about your role?

I love being able to work across so many different types of projects in various phases of drug development, ranging from the more strategic issues involved in the launch of a drug, to demonstrating their value in the post-approval phase.  

On a personal level, it is particularly rewarding when I get to work on projects that improve access to treatments for cancer. The fast-paced and constantly evolving market access landscape ensures that you never get bored! 

Can you share a memorable Servier moment?

There have been several great moments for me at Servier, but the most recent one was when many of us came together to celebrate the grand opening of our new office space in the Boston Seaport. It was very exciting to meet old colleagues and make some new connections. It was a fun evening and I look forward to creating many more memories at Servier. 

Servier Pharmaceuticals Partners with Artists for Humanity

Read More

Servier Summer Interns Share Their Experiences

Read More

Servier Statement on U.S. Supreme Court Overturning Roe v. Wade

Read More